Cargando…

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)

AIMS/HYPOTHESIS: In an individual-level analysis we examined the effect of atorvastatin on glycaemia progression in type 2 diabetes and whether glycaemia effects reduce the prevention of cardiovascular disease (CVD) with atorvastatin. METHODS: The study population comprised 2,739 people taking part...

Descripción completa

Detalles Bibliográficos
Autores principales:	Livingstone, Shona J., Looker, Helen C., Akbar, Tahira, Betteridge, D. John, Durrington, Paul N., Hitman, Graham A., Neil, H. Andrew W., Fuller, John H., Colhoun, Helen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705133/ https://www.ncbi.nlm.nih.gov/pubmed/26577796 http://dx.doi.org/10.1007/s00125-015-3802-6

Ejemplares similares

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2015)

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial
por: Colhoun, Helen M., et al.
Publicado: (2011)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
por: Deshmukh, Harshal A., et al.
Publicado: (2012)

Serum kidney injury molecule 1 and β(2)-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes
por: Colombo, Marco, et al.
Publicado: (2018)

Effects of Atorvastatin on Nitrate Tolerance in Diabetic Rats
por: Imenshahidi, Mohsen, et al.
Publicado: (2010)

Effects of atorvastatin on autophagy in skeletal muscles of diabetic rats
por: Yang, Bingquan, et al.
Publicado: (2018)

Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland†
por: Hothersall, Eleanor J, et al.
Publicado: (2014)

Rosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia
por: Abbas, Ahmed, et al.
Publicado: (2012)

Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy
por: Carillion, Aude, et al.
Publicado: (2017)

Atorvastatin-induced pancreatitis
por: Prajapati, Samir, et al.
Publicado: (2010)

Atorvastatin (Lipitor) by MCR
por: Zarganes-Tzitzikas, Tryfon, et al.
Publicado: (2019)

The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes
por: Davenport, Colin, et al.
Publicado: (2015)

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy
por: Takazakura, Akiko, et al.
Publicado: (2015)

Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
por: Paseban, Maryam, et al.
Publicado: (2019)

The Efficacy of Fenofibrate in Addition to Atorvastatin in Patients of Type II Diabetes Mellitus
por: Qasim, Muhammad, et al.
Publicado: (2022)

Atorvastatin solid dispersion for bioavailability enhancement
por: Shamsuddin,, et al.
Publicado: (2016)

Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
por: Dakin, Helen A., et al.
Publicado: (2020)

Atorvastatin-induced acute pancreatitis
por: Deshpande, Prasanna R., et al.
Publicado: (2011)

Bioenhancing effects of naringin on atorvastatin
por: Sama, Venkatesh, et al.
Publicado: (2019)

Atorvastatin-Induced Refractory Thrombocytopenia
por: Ghuman, Jasmine, et al.
Publicado: (2021)

Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): a population-based observational study
por: Walker, Jeremy, et al.
Publicado: (2017)

Effect of atorvastatin and hydroxychloroquine combination on blood glucose in alloxan-induced diabetic rats
por: Pareek, Anil, et al.
Publicado: (2009)

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
por: Krysiak, Robert, et al.
Publicado: (2010)

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
por: Barakat, Lolwa, et al.
Publicado: (2013)

The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model
por: Zhou, Xiaojun, et al.
Publicado: (2016)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
por: Han, Eugene, et al.
Publicado: (2017)

Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction
por: Yu, You, et al.
Publicado: (2021)

Computational drug repositioning of atorvastatin for ulcerative colitis
por: Bai, Lawrence, et al.
Publicado: (2021)

Atorvastatin Induced Erythrocytes Membrane Blebbing
por: Rana, Rumaisa Bashir, et al.
Publicado: (2019)

Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization
por: Al-Kazemi, Reham, et al.
Publicado: (2019)

Atorvastatin: DRESS syndrome: case report
Publicado: (2021)

Spectroscopic studies on photodegradation of atorvastatin calcium
por: Oprica, Madalina, et al.
Publicado: (2021)

Atorvastatin: Acute pancreatitis: case report
Publicado: (2021)

Physically Targeted Intravenous Polyurethane Nanoparticles for Controlled Release of Atorvastatin Calcium
por: Eftekhari, Behnaz Sadat, et al.
Publicado: (2017)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study
por: Livingstone, Shona J., et al.
Publicado: (2012)

Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
por: Mita, Tomoya, et al.
Publicado: (2013)

Prevention of Arterial Stiffening by Using Low-Dose Atorvastatin in Diabetes Is Associated with Decreased Malondialdehyde
por: Wang, Chih-Hsien, et al.
Publicado: (2014)

Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus
por: Jiang, Hua, et al.
Publicado: (2019)

Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice
por: Thomsen, Maria L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6s8o9obcsc7c1u65itftc61ens